Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction

Clinical Cardiology

Volumn 26, Issue 3, 2003, Pages 153-157

  Inoue, Teruo ^a   Yaguchi, Isao ^a   Mizoguchi, Keiichi ^a   Uchida, Toshihiko ^a   Takayanagi, Kan ^a   Hayashi, Terumi ^a   Morooka, Shigenori ^a   Eguchi, Yutaka ^b  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Acute myocardial infarction; Coronary stent; Plasminogen activator inhibitor 1; Restenosis

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTERY LESION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DISEASE COURSE; EMERGENCY SURGERY; EXPERIENCE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE REGRESSION; PREDICTION; PROTEIN FUNCTION; RESTENOSIS; STATISTICAL SIGNIFICANCE;

EID: 0037339741     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960260311     Document Type: Article

References (20)

1. Schwartz RS, Huber KC, Murphy JC, Edwards WD, Camrud AR, Vliestra RE, Holmes DR: Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274
2. Schwartz RS, Murphy JC, Edwards WD, Camrud AR, Vliestra RE, Holmes DR: Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200
3. Saksela O, Rifkin D: Cell-associated plasminogen activation: Regulation and physiological function. Ann Rev Cell Biol 1988;4:93-126
4. Hirashima O, Ogawa H, Oshima S, Sakamoto T, Honda Y, Sakata S, Masuda T, Miyao Y, Yasue H: Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: Difference between thrombolytic therapy and direct coronary angioplasty. Am Heart J 1995;130:933-939
5. Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ: Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Thromb Haemost 1999;82:104-108
6. Kohno H: High sensitive latex photometric immunoassay in clinical chemistry. In Progress in Clinical Chemistry (Eds. Miyai K, Kanno T, Ishikawa E), p. 225-229. Oxford, UK: Elsevier Science, 1992
7. Ono T, Ogura M, Furusaki F, Watanabe F, Sakata Y: The ratio of plasmin-α2-plasmin inhibitor complex to plasminogen activator inhibitor-1 reflects the fibrinolytic potential in plasma. Fibrinolysis Proteol 2000:14;(suppl 1):72
8. Brack MJ, More RS, Pringle S, Gershlick AH: Absence of a prothrombotic state in restenotic patients? Coron Artery Dis 1994;5:501-506
9. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D: Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1995;92:31-38
10. Benchimol D, Bonnet J, Benchimol H, Drouillet F, Duplaa C, Couffinhal T, Desgranges C, Bricaud H: Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Int J Cardiol 1993;38:7-18
11. Sakata K, Miura F, Sugino H, Shinobe M, Shirotani M, Yoshida H, Mori N, Hoshino T, Takada A: Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis. Am Heart J 1996;131:1-6
12. Huber K, Jorg M, Probst P, Schuster E, Lang I, Kaindl F, Binder BR: A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis. Thromb Haemost 1992;67:209-213
13. Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A: Postangioplasty restenosis: Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 1997;133:387-392
14. Shah PK, Amin J: Low high-density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation 1992;85:1279-1285
15. Strauss BH, Lau HK, Bowman KA, Sparkes J, Chisholm RJ, Garvey MB, Fenkell LL, Natarajan MK, Singh I, Teitel JM: Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 1999;100:1616-1622
16. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992;89:6998-7002
17. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EK: Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993;13:1090-1100
18. Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD: Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice. Circulation 1997;96:3180-3191
19. He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989;86:2632-2636
20. Tkachuk V, Stepanova V, Little PJ, Bobik A: Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol 1996;23:759-765